PathAI

back to Directory

PathAI

PathAI logo

Website
http://pathai.com/

Founded
2016

Patents
2

Publications
59

Technologies

AI Companies (Drug Discovery)

PathAI's mission is to improve patient outcomes with AI-powered pathology. Our platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning.

digital pathology immuno-oncology companion diagnostics precision medicine computational pathology

Posts Mentioning This Company

9 Companies Using AI to Improve Clinical Trials to Watch in 2023

9 Notable AI Companies in Clinical Research to Watch in 2023

The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% for drug candidates moving from Phase 1 towards approval. Even if the drug candidate is safe and efficacious, clinical trials might fail due to the lack of financing, insufficient enrollment, …

6 Ways Big Pharma Leverages AI To Boost Drug Discovery

How Big Pharma Adopts AI To Boost Drug Discovery

(Last updated: July 2023) The type of artificial intelligence (AI) which scares business leaders, experts, and activists all over the world, is called “general artificial intelligence"—the one which could “think” pretty much like humans do, and which could quickly evolve into a dangerous “superintelligence”. There is a notion that it …

Introducing PathExplore, a Game-Changing AI Tool for In-Depth Tumor Microenvironment Exploration

As we continue to make progress in oncology therapeutics, researchers are constantly seeking ways to improve patient outcomes by understanding the complexities of the tumor microenvironment (TME). In response to this demand, PathAI, an innovator in AI-powered pathology, has announced the launch of PathExplore™, an innovative solution that could potentially …